Cat. No. | Product name | CAS No. |
DCAPI1356 |
Epalrestat
Epalrestat |
82159-09-9 |
DC28180 |
Lidorestat
Lidorestat (IDD-676) is a potent, selective and orally active aldose reductase inhibitor with an IC50 of 5 nM. Lidorestat can be used for chronic diabetes complications. Lidorestat also improves nerve conduction and reduces cataract formation. |
245116-90-9 |
DC45829 |
Myrciacetin
Myrciacetin is a flavonoid from Rhododendron dauricum. Myrciacetin is against rat lens aldose reductase with an IC50 of 13 μM. |
203734-35-4 |
DC46017 |
Zenarestat
Zenarestat is a potent and orally active aldose reductase inhibitor. Zenarestat improves diabetic peripheral neuropathy in Zucker diabetic fatty rats. |
112733-06-9 |
DC49722 |
Aldose reductase-IN-3
Aldose reductase-IN-3 (Compound 5) is a potent and moderately selective inhibitor of aldose reductase (AR) with an IC50 of 3.99 μM. Aldose reductase has recently emerged as a molecular target that is involved in various inflammatory diseases, including sepsis. Aldose reductase-IN-3 has the potential for the research of sepsis. |
1390616-76-8 |
DC49723 |
Aldose reductase-IN-2
Aldose reductase-IN-2 (Compound 5f) is a potent inhibitor of aldose reductase (AR). Aldose reductase-IN-2 has antioxidation capacity. Aldose reductase-IN-2 is a promising anti-diabetic complications agent. |
1687735-82-5 |